GGrantIndex
← Leaderboards

Val C Sheffield

University Of Iowa

$29,509,881
Attributed
$34,339,918
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$39,969,025 · 15

By mechanism

R01$30,392,640 · 8
P30$6,074,856 · 2
P01$2,009,882 · 1
P50$1,074,995 · 2
R21$393,647 · 1
P41$23,005 · 1

Top collaborators

Most similar at University Of Iowa

Same institution · by research overlap

Others in their field

Top investigators on “Insight

Research focus

InsightGeneticMouse ModelGenesPhenotypePathway InteractionsMutationLeadGene ExpressionBaseBardet-Biedl SyndromeFunctional DisorderBlindnessGenotypeGene MutationMolecularObesityPlayDiabetes MellitusResearch PersonnelHypertensionPreventCommunitiesAffect

Grant awards (91)

Multidisciplinary Investigations in Visual Science$525,300
P30 · FY2025 · EY · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$421,653
R01 · FY2025 · DK · contact PI
Administrative Core$78,121
P30 · FY2025 · EY · contact PI
Multidisciplinary Investigations in Visual Science$618,000
P30 · FY2024 · EY · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$449,766
R01 · FY2024 · DK · contact PI
Administrative Core$91,907
P30 · FY2024 · EY · contact PI
Multidisciplinary Investigations in Visual Science$618,000
P30 · FY2023 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$473,396
R01 · FY2023 · EY · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$468,507
R01 · FY2023 · DK · contact PI
Administrative Supplement for Research on Vitamin B3 Dietary Supplements for Eye Disease$149,340
R01 · FY2023 · EY · contact PI
Administrative Core$91,907
P30 · FY2023 · EY · contact PI
Multidisciplinary Investigations in Visual Science$618,000
P30 · FY2022 · EY · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$468,501
R01 · FY2022 · DK · contact PI
Novel Genome Editing for the Treatment of Glaucoma$459,195
R01 · FY2022 · EY · contact PI
Evaluation of Orthogonally Oriented Electromagnetic Fields to Stabilize ROS, Induce DNA damage and Improve Survival in Non-Small Cell Lung Cancer$176,961
R21 · FY2022 · CA
Administrative Core$91,907
P30 · FY2022 · EY · contact PI
Multidisciplinary Investigations in Visual Science$618,000
P30 · FY2021 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$527,925
R01 · FY2021 · EY · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$468,501
R01 · FY2021 · DK · contact PI
Evaluation of Orthogonally Oriented Electromagnetic Fields to Stabilize ROS, Induce DNA damage and Improve Survival in Non-Small Cell Lung Cancer$216,686
R21 · FY2021 · CA
Administrative Core$91,907
P30 · FY2021 · EY · contact PI
Multidisciplinary Investigations in Visual Science$521,024
P30 · FY2020 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$477,939
R01 · FY2020 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$70,857
R01 · FY2020 · EY · contact PI
Multidisciplinary Investigations in Visual Science$521,024
P30 · FY2019 · EY · contact PI
Novel Genome Editing for the Treatment of Glaucoma$491,564
R01 · FY2019 · EY · contact PI
Multidisciplinary Investigations in Visual Science$525,599
P30 · FY2018 · EY · contact PI
Novel Glaucoma Treatment Using Genome Editing$508,361
R01 · FY2018 · EY · contact PI
Multidisciplinary Investigations in Visual Science$528,649
P30 · FY2017 · EY · contact PI
Novel Glaucoma Treatment Using Genome Editing$508,361
R01 · FY2017 · EY · contact PI
Complex Mechanisms in Bardet-Biedl Syndrome Retinopathy$490,397
R01 · FY2017 · EY · contact PI
Treatment of a Complex Retinal Degenerative Syndrome$437,246
R01 · FY2017 · EY · contact PI
Role of Neural Progenitor Cells in the Development of Neonatal Hydrocephalus$330,313
R01 · FY2017 · NS · contact PI
Multidisciplinary Investigations in Visual Science$535,511
P30 · FY2016 · EY · contact PI
Novel Glaucoma Treatment Using Genome Editing$508,361
R01 · FY2016 · EY · contact PI
Complex Mechanisms in Bardet-Biedl Syndrome Retinopathy$490,397
R01 · FY2016 · EY · contact PI
Treatment of a Complex Retinal Degenerative Syndrome$437,246
R01 · FY2016 · EY · contact PI
Role of Neural Progenitor Cells in the Development of Neonatal Hydrocephalus$330,313
R01 · FY2016 · NS · contact PI
Novel Glaucoma Treatment Using Genome Editing$508,558
R01 · FY2015 · EY · contact PI
Complex Mechanisms in Bardet-Biedl Syndrome Retinopathy$480,589
R01 · FY2015 · EY · contact PI
Treatment of a Complex Retinal Degenerative Syndrome$428,500
R01 · FY2015 · EY · contact PI
Role of Neural Progenitor Cells in the Development of Neonatal Hydrocephalus$330,313
R01 · FY2015 · NS · contact PI
Novel Glaucoma Treatment Using Genome Editing$558,268
R01 · FY2014 · EY · contact PI
Complex Mechanisms in Bardet-Biedl Syndrome Retinopathy$480,589
R01 · FY2014 · EY · contact PI
Treatment of a Complex Retinal Degenerative Syndrome$428,502
R01 · FY2014 · EY · contact PI
Role of Neural Progenitor Cells in the Development of Neonatal Hydrocephalus$327,010
R01 · FY2014 · NS · contact PI
Complex Mechanisms in Bardet-Biedl Syndrome Retinopathy$490,397
R01 · FY2013 · EY · contact PI
Treatment of a Complex Retinal Degenerative Syndrome$437,248
R01 · FY2013 · EY · contact PI
Role of Neural Progenitor Cells in the Development of Neonatal Hydrocephalus$330,313
R01 · FY2013 · NS · contact PI
Interdisciplinary approach to retinal disease gene identification$563,706
R01 · FY2011 · EY · contact PI
Evaluation of complex inheritance of retinal degeneration in Bardet-Biedl Syndrom$521,090
R01 · FY2011 · EY · contact PI
Mechanisms of Hypertension and Obesity in Mouse Models of a Human Obesity Synd$400,831
P01 · FY2011 · HL · contact PI
Interdisciplinary approach to retinal disease gene identification$570,094
R01 · FY2010 · EY · contact PI
Evaluation of complex inheritance of retinal degeneration in Bardet-Biedl Syndrom$526,991
R01 · FY2010 · EY · contact PI
Molecular Genetics of Glaucoma$437,501
R01 · FY2010 · EY · contact PI
Mechanisms of Hypertension and Obesity in Mouse Models of a Human Obesity Synd$400,831
P01 · FY2010 · HL · contact PI
Interdisciplinary approach to retinal disease gene identification$667,195
R01 · FY2009 · EY · contact PI
Interdisciplinary approach to retinal disease gene identification$559,078
R01 · FY2009 · EY · contact PI
Evaluation of complex inheritance of retinal degeneration in Bardet-Biedl Syndrom$516,810
R01 · FY2009 · EY · contact PI
Molecular Genetics of Glaucoma$451,797
R01 · FY2009 · EY · contact PI
Mechanisms of Hypertension and Obesity in Mouse Models of a Human Obesity Synd$400,831
P01 · FY2009 · HL · contact PI
Molecular Genetics of Glaucoma$562,071
R01 · FY2008 · EY · contact PI
Interdisciplinary approach to retinal disease gene identification$531,937
R01 · FY2008 · EY · contact PI
Evaluation of complex inheritance of retinal degeneration in Bardet-Biedl Syndrom$491,655
R01 · FY2008 · EY · contact PI
Mechanisms of Hypertension and Obesity in Mouse Models of a Human Obesity Synd$392,815
P01 · FY2008 · HL · contact PI
Evaluation of complex inheritance of retinal degeneration in Bardet-Biedl Syndrom$517,142
R01 · FY2007 · EY · contact PI
Molecular Genetics of Glaucoma$513,411
R01 · FY2007 · EY · contact PI
Mechanisms of Hypertension and Obesity in Mouse Models of a Human Obesity Synd$414,574
P01 · FY2007 · HL · contact PI
Interdisciplinary approach to retinal disease gene identification$374,480
R01 · FY2007 · EY · contact PI
Interdisciplinary approach to retinal disease gene identification$151,777
R01 · FY2007 · EY · contact PI
Molecular Genetics of Glaucoma$519,603
R01 · FY2006 · EY · contact PI
Molecular Biology of Syndromic Retinal Degeneration$497,403
R01 · FY2006 · EY · contact PI
Molecular Biology of Syndromic Retinal Degeneration$494,896
R01 · FY2005 · EY
Identification of genes involved in human hypertension$444,263
P50 · FY2005 · HL
Molecular Biology of Syndromic Retinal Degeneration$480,840
R01 · FY2004 · EY
MOLECULAR GENETICS OF HEREDITARY GLAUCOMA$447,955
R01 · FY2004 · EY
Identification of genes involved in human hypertension$431,324
P50 · FY2004 · HL
Molecular Biology of Syndromic Retinal Degeneration$2,280
R01 · FY2004 · EY
Molecular Biology of Syndromic Retinal Degeneration$469,282
R01 · FY2003 · EY
MOLECULAR GENETICS OF HEREDITARY GLAUCOMA$437,228
R01 · FY2003 · EY
MOLECULAR GENETICS OF HEREDITARY GLAUCOMA$451,177
R01 · FY2002 · EY
Molecular Biology of Syndromic Retinal Degeneration$437,906
R01 · FY2002 · EY
Identification of genes involved in human hypertension$0
P50 · FY2002 · HL
A PROGRAM FOR RAT GENE DISCOVERY AND MAPPING$1,675,260
R01 · FY2001 · HL
MOLECULAR GENETICS OF HEREDITARY GLAUCOMA$448,582
R01 · FY2001 · EY
MOLECULAR BIOLOGY OF SYNDROMIC RETINAL DEGENERATION$211,115
R01 · FY2001 · EY
Identification of genes involved in human hypertension$0
P50 · FY2001 · HL
A PROGRAM FOR RAT GENE DISCOVERY AND MAPPING$1,626,470
R01 · FY2000 · HL
MOLECULAR GENETICS OF HEREDITARY GLAUCOMA$467,482
R01 · FY2000 · EY
CORE--MOLECULAR GENOTYPING$199,408
P50 · FY2000 · HL
IMAGING OF DEFECTS IN OFFSPRING OF MUTAGENIZED MICE$23,005
P41 · FY2000 · RR